In the last trading session, 6.18 million SILO Pharma Inc (NASDAQ:SILO) shares changed hands as the company’s beta touched 1.49. With the company’s per share price at $0.58 changed hands at -$0.06 or -9.20% during last session, the market valuation stood at $4.19M. SILO’s last price was a discount, traded about -675.86% off its 52-week high of $4.50. The share price had its 52-week low at $0.41, which suggests the last value was 29.31% up since then.

SILO Pharma Inc (NASDAQ:SILO) trade information

Instantly SILO was in red as seen at the end of in last trading. With action 30.76%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -34.71%, with the 5-day performance at 30.76% in the green. However, in the 30-day time frame, SILO Pharma Inc (NASDAQ:SILO) is -28.26% down.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 11.18%.

SILO Dividends

SILO Pharma Inc is expected to release its next quarterly earnings report in July.

FINANCIAL ADVOCATES INVESTMENT MANAGEMENT holds the second largest percentage of outstanding shares, with 0.7842% or 23938.0 shares worth $23938.0 as of 2024-06-30.

Among Mutual Funds, the top two as of Apr 30, 2025 were AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 164.24 shares estimated at $95437.0 under it, the former controlled 0.17% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.03% of the shares, roughly 25.8 shares worth around $14995.0.